Tag Archives: AIDS/HIV

Innovation Others Patent

Innovation, Progress, Ambition and Censorship


I recently came across two very interesting articles, the ideas of which our policy makers would do well to keep in mind. The first, a broadly focused piece, titled “Between Innovation and Progress“ is a response by Prof Siva Vaidhyanathan (Univ of Virginia) to the interestingly poised question “Has “innovation” supplanted the idea of progress?“. The second piece, more specific to India, is the opening editorial in the “Science in India” special issue of the highly respected “Nature” science journal, titled…


Read More »
Patent

Mylan gets green light to export HIV drugs to Venezuela


At a time when the DHC is coming under the scanner for some controversial ex parte interim injunction orders in high stakes disputes, it is heartening to read a well reasoned order by the AP/Telangana HC in the patent infringment matter between Bristol-Myers Squibb (BMS) and Mylan over anti-retroviral drug ‘Atazanavir’. On 5th December, Justice A. Rajasheker Reddy rejected an appeal against the trial court decision denying the interim injunction application, noting that the applicants failed to demonstrate a prima facie case. [Warning: Long…


Read More »
Patent

Negotiating licenses between patent holders and generic producers: the Medicines Patent Pool


The Medicines Patent Pool (MPP), backed by the United Nations, is a mechanism that has been formed with the intention of increasing access to HIV medicines in the developing world by increasing their affordability. The MPP negotiates licenses between patent holders and generic producers to make and sell HIV medicines at affordable prices to those who need it. An analysis of the concept of patent pools can be found here and here.   The latest is the license negotiated by the…


Read More »

SpicyIP Tidbit: Thai Govt. plans to issue compulsory license for antiretroviral


The Thailand Government announced plans to issue a compulsory licence for an anti-retroviral drug Efaverenz, as reported by IP Komodo (a blog covering South East Asian IP developments). Thailand has previously issued licences for other anti-cancer drugs, but this is a first for an anti-retroviral drug(used in second-line treatment for HIV-AIDS). The drug is manufactured by Merck. Plans for issuance of licence were announced  way back in 2006. In 2007 it was reported that Merck had substantially reduced prices for AIDS…


Read More »

SpicyIP Tidbit: ViiV Healthcare collaborates with Medicines Patent Pool (MPP)


Image from here Medicines Patent Pool (MPP) announced the launch of a new collaboration with ViiV Healthcare – a joint venture between GlaxoSmithKline (76.5%), Pfizer (13.5%), and Shionogi (10%) – to facilitate greater availability of critically needed medicines for children living with HIV. ViiV Healthcare is the second research-based pharmaceutical business to join the Medicines Patent Pool, the first being Gilead Sciences. We blogged about the MPP here, here, here and here. As has been noted, MPP was launched in…


Read More »

SpicyIP Tidbit: Indian generic companies now step into MPP


Indian generics Aurobindo Pharma Limited and MedChem, yesterday joined the Medicines Patent Pool (MPP) for the manufacture of several antiretroviral medicines. While Aurobindo is a well established generic unit which already produces antiretrovirals, MedChem is apparently a new comer into the HIV field. [The MPP is a patent pool which seeks to facilitate the innovation and production of ARVs in developing countries — we have written on it before here] This will allow Aurobindo to have access and produce the products that Gilead…


Read More »
Innovation Patent

Gilead dips its toes into Patent Pool


Earlier this year, we had carried a post on UNITAID’s Medicines Patent Pool being in talks with several key pharmaceutical companies. In a press release by the Medicines Patent Pool today, they announced an agreement with Gilead Sciences, which makes them the first pharmaceutical company to join the MPP. Gilead also announced that they had already established license agreements with 4 India based drug manufacturers – Hetero Drugs Ltd., Matrix Laboratories Ltd., Ranbaxy Laboratories Ltd. and Strides Arcolab Ltd Patent Pools…


Read More »
Patent

SpicyIP Tidbit: Medicines Patent Pool in talks with Big Pharma


UNITAID’s Medicines Patent Pool which received it’s first patent late last year is now making more headway by entering into negotiations with several key HIV medicines patent holders. Patent pools work by allowing patent holders to share their IP with other parties via licences. The working of this patent pool in particular therefore relied on the key patent holders contributing their patents to the pool for it work. To the skeptics (me included) of how well this would work, there is…


Read More »

India, South Africa gain from J&J-generic deal, Patent Pool loses out


Johnson & Johnson’s subsidiary Tibotec has granted multiple non-exclusive licenses for a new HIV-AIDS treatment to generic manufacturers including Hetero Drugs Ltd, Matrix Laboratories Ltd from India and Aspen Pharmacare from South Africa. The drug in question, rilpivirine hydrochloride (TMC278)  is still pending approval however. Tibotec would recieve 2-5% of what is received for the pills. The press release by Tibotec is available here.  The licensing allows the Indian generic companies to manufacture, market and distribute TMC278 in Least Developed Countries, Sub-Saharan…


Read More »


The Big Bad Wolf as the friendly next-door neighbor(A mixture of the Wolf in Little Red Riding Hood, and the Wolf in The Three Little Pigs, he is a friendly misunderstood crossdresser whom the Fairy Godmother unaffectionately refers to as “some gender confused wolf.” He appears to still be wearing Lil Red’s grandmother’s clothes and is apparently on good terms with the three little pigs. In Far Far Away Idol, he sings “Hungry Like the Wolf”. In recent “Shrek The…


Read More »